This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMedMen Enterprises (MMEN) 주식 개요Operates as a cannabis retailer in the United States. 자세히 보기MMEN 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당0/6위험 분석마이너스 주주 지분주식은 유동성이 매우 낮습니다지난 1년 동안 매출이 17.4% 감소했습니다.의미 있는 시가총액이 없습니다(CA$24M)+ 위험 2건 추가모든 위험 점검 보기MMEN Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW481,017 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA481,017 investors already sharing narrativesYour Fair ValueCA$Current PriceN/A해당 없음내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-220m161m2016201920222025202620282031Revenue US$120.1mEarnings US$18.0mAdvancedSet Fair ValueView all narrativesMedMen Enterprises Inc. 경쟁사YourWay Cannabis BrandsSymbol: CNSX:YOURMarket cap: CA$23.2mDevonian Health GroupSymbol: TSXV:GSDMarket cap: CA$28.2mRubicon OrganicsSymbol: TSXV:ROMJMarket cap: CA$30.4mCharlotte's Web HoldingsSymbol: TSX:CWEBMarket cap: CA$86.8m가격 이력 및 성과MedMen Enterprises 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가CA$052주 최고가CA$0.0552주 최저가CA$0.015베타1.41개월 변동n/a3개월 변동n/a1년 변동n/a3년 변동n/a5년 변동n/aIPO 이후 변동n/a최근 뉴스 및 업데이트공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$27m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$357m). Earnings have declined by 16% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.1% increase in shares outstanding). Market cap is less than US$100m (CA$50.8m market cap, or US$37.2m).분석 기사 • Aug 16Why Investors Shouldn't Be Surprised By MedMen Enterprises Inc.'s (CSE:MMEN) Low P/SMedMen Enterprises Inc.'s ( CSE:MMEN ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing...공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.더 많은 업데이트 보기Recent updates공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$27m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$357m). Earnings have declined by 16% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.1% increase in shares outstanding). Market cap is less than US$100m (CA$50.8m market cap, or US$37.2m).분석 기사 • Aug 16Why Investors Shouldn't Be Surprised By MedMen Enterprises Inc.'s (CSE:MMEN) Low P/SMedMen Enterprises Inc.'s ( CSE:MMEN ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing...공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.공고 • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.공고 • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.Reported Earnings • Feb 05Second quarter 2023 earnings released: US$0.011 loss per share (vs US$0.006 loss in 2Q 2022)Second quarter 2023 results: US$0.011 loss per share (further deteriorated from US$0.006 loss in 2Q 2022). Revenue: US$29.6m (down 17% from 2Q 2022). Net loss: US$14.0m (loss widened 103% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.Board Change • Dec 09High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • Sep 10MedMen Enterprises Inc. announced delayed annual 10-K filingOn 09/09/2022, MedMen Enterprises Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.Reported Earnings • Sep 09Full year 2022 earnings released: US$0.13 loss per share (vs US$0.22 loss in FY 2021)Full year 2022 results: US$0.13 loss per share. Revenue: US$140.8m (down 2.9% from FY 2021). Net loss: US$149.8m (loss widened 27% from FY 2021).공고 • Aug 24An unknown buyer completed the acquisition of Substantially All of the Florida Assets of MedMen for $67 million.An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million on February 28, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The transaction is subject to pending receipt of all required contractual consents and governmental approvals including the requisite change of ownership approval from the Florida Office of Medical Marijuana Use and it is expected to close in late April or early May 2022. The agreement may be terminated, if the agreement is illegal or prohibited by the law, or if any of the conditions have not been satisfied by July 31, 2022. Hyperion Capital Inc. provided a fairness opinion to the special committee of the board of directors of MedMen. An unknown buyer completed the acquisition of Substantially All of the Florida Assets of MedMen on August 22, 2022. The deal is comprised of $63 million in cash and approximately $4 million in liabilities to be assumed by the buyer. The deal also includes the license of MedMen’s trademarks in the state.Board Change • Jun 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • May 24+ 1 more updateMedMen Enterprises Inc. Announces Leaving of Tyson Rossi, Chief Strategy Officer, Effective June 3, 2022MedMen Enterprises Inc. announced Tyson Rossi, Chief Strategy Officer, is leaving MedMen, effective June 3, 2022. Moving forward, the role will be filled internally.공고 • May 12Ascend Wellness Holdings, Inc. (CNSX:AAWH.U) entered into a definitive agreement to acquire New York Operations of MedMen Enterprises Inc. for $88 million.Ascend Wellness Holdings, Inc. (CNSX:AAWH.U) entered into a definitive agreement to acquire New York Operations of MedMen Enterprises Inc. for $88 million on May 11, 2022. The transaction resolves the litigation between MedMen and AWH concerning the transaction and delivers $15 million in additional value to MedMen shareholders. Under the terms of the settlement agreement, AWH will pay MedMen $88 million: $73 million as an assumption of debt and $15 million in cash. Other terms of the transaction will be as originally announced in February 2021. The transaction is expected to close within thirty days.Reported Earnings • May 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: US$0.02 loss per share (up from US$0.039 loss in 3Q 2021). Revenue: US$35.2m (up 10% from 3Q 2021). Net loss: US$19.2m (loss narrowed 10% from 3Q 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) also missed analyst estimates by 487%.공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Appointment of Edward Record as Chief Executive OfficerMedMen Enterprises Inc. announced the appointment of Edward Record as Chief Executive Officer, effective immediately. Record succeeds interim CEO Michael Serruya, who will continue to serve as Chairman of the Board. Record joined MedMen’s Board of Directors in 2021. He previously served as the Chief Financial Officer for Hudson's Bay Company, whose U.S. holdings include Saks Fifth Avenue. Before joining HBC, Record was Chief Financial Officer for J.C. Penney. Prior to J.C. Penney, Record held leadership positions at Stage Stores, Kohl’s and Belk.Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.공고 • Mar 01An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million.An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million on February 28, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The transaction is expected to close in late April or early May 2022, pending the receipt of all required contractual consents and governmental approvals including the requisite change of ownership approval from the Florida Office of Medical Marijuana Use. Hyperion Capital Inc. provided a fairness opinion to the special committee of the board of directors of MedMen.공고 • Feb 19MedMen Announces CFO ChangesMedMen Enterprises Inc. announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners.공고 • Feb 13MedMen Announces Resignation of Tracy Mccourt as Chief Revenue Officer, Effective March 4, 2022MedMen Enterprises Inc. announced the Company has received notification from Tracy McCourt, the Company’s Chief Revenue Officer, of her decision to resign, effective March 4, 2022.Reported Earnings • Feb 10Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: US$0.011 loss per share (up from US$0.083 loss in 2Q 2021). Revenue: US$39.1m (up 36% from 2Q 2021). Net loss: US$13.5m (loss narrowed 66% from 2Q 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 487%.공고 • Feb 06MedMen Enterprises Inc., Annual General Meeting, Apr 20, 2022MedMen Enterprises Inc., Annual General Meeting, Apr 20, 2022.공고 • Feb 02MedMen Enterprises Inc. Announces Cannasseur Personal Concierge ServiceMedMen Enterprises Inc. announced its Cannasseur Personal Concierge Service, a personal shopping program now available in California, Nevada, Arizona and Florida dispensaries. Led by MedMen’s top in-store cannabis experts, or ‘Cannaseurs’, the service offers customers free one-on-one consultations with seasoned budtenders, covering everything from individualized product and strain recommendations to cannabis education and responsible use. Every MedMen Cannasseur receives expert training through in-depth cannabis workshops and seminars with leading industry experts. A typical session will include questions about a consumer’s experience level, desired effect and preferred consumption format. Bringing best-in-class knowledge of cannabinoids, terpenes, cultivation methods, consumption formats and product offerings, their Cannaseurs take pride in advising and guiding patients towards the best product for their personal needs.공고 • Jan 16Ascend Wellness Holdings, Inc. Announces the Filing of A Lawsuit and Motion for Preliminary Injunction for Specific Performance to Close Transaction with MedMenAscend Wellness Holdings, Inc. announced it has filed a complaint commencing a lawsuit in the Commercial Division of the Supreme Court of the State of New York in New York County against MedMen NY, Inc. and MM Enterprises USA, LLC in which AWH is seeking an order compelling specific performance of the transactions contemplated by the Investment Agreement among AWH and MedMen. In addition, AWH has made an application for a preliminary injunction and temporary restraining order to maintain the status quo between the parties and to prevent any actions by the MedMen parties that would result in additional encumbrances on the equity or assets of MedMen NY, Inc.Board Change • Jan 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Board Change • Dec 03High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.주주 수익률MMENCA PharmaceuticalsCA 시장7Dn/a-0.9%-0.3%1Yn/a21.2%30.2%전체 주주 수익률 보기수익률 대 산업: MMEN의 Canadian Pharmaceuticals 산업 대비 성과를 판단하기에 데이터가 부족합니다.수익률 대 시장: MMEN의 Canadian 시장 대비 성과를 판단하기에 데이터가 부족합니다.주가 변동성Is MMEN's price volatile compared to industry and market?MMEN volatilityMMEN Average Weekly Movementn/aPharmaceuticals Industry Average Movement8.5%Market Average Movement9.4%10% most volatile stocks in CA Market16.3%10% least volatile stocks in CA Market3.7%안정적인 주가: MMEN는 지난 3개월 동안 Canadian 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: Insufficient data to determine MMEN의 변동성 변화를 판단할 수 없습니다.회사 소개설립직원 수CEO웹사이트n/a428n/awww.medmen.com더 보기MedMen Enterprises Inc. 기초 지표 요약MedMen Enterprises의 순이익과 매출은 시가총액과 어떻게 비교됩니까?MMEN 기초 통계시가총액CA$23.81m순이익 (TTM)-CA$143.31m매출 (TTM)CA$120.12m0.0x주가매출비율(P/S)0.0x주가수익비율(P/E)MMEN는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표MMEN 손익계산서 (TTM)매출US$120.12m매출원가US$63.44m총이익US$56.68m기타 비용US$199.99m순이익-US$143.31m최근 보고된 실적Mar 25, 2023다음 실적 발표일해당 없음주당순이익(EPS)-0.094총이익률47.18%순이익률-119.30%부채/자본 비율-82.3%MMEN의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/05/19 03:37종가2024/04/08 00:00수익2023/03/25연간 수익2022/06/25데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MedMen Enterprises Inc.는 9명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관David McFadgenATB Cormark Historical (Cormark Securities)Matt BottomleyCanaccord GenuityPablo ZuanicCantor Fitzgerald & Co.6명의 분석가 더 보기
공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.
공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.
공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$27m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$357m). Earnings have declined by 16% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.1% increase in shares outstanding). Market cap is less than US$100m (CA$50.8m market cap, or US$37.2m).
분석 기사 • Aug 16Why Investors Shouldn't Be Surprised By MedMen Enterprises Inc.'s (CSE:MMEN) Low P/SMedMen Enterprises Inc.'s ( CSE:MMEN ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing...
공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.
공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Resignation of DirectorsMedMen Enterprises Inc. announced that it made an assignment into bankruptcy pursuant to Canadas Bankruptcy and Insolvency Act (the Bankruptcy Proceedings) on April 24, 2024 and B. Riley Farber Inc. was appointed as the Company's bankruptcy trustee (in such capacity, the Bankruptcy Trustee). The each of the Company's directors resigned effective immediately prior to the commencement of the Bankruptcy Proceedings.
공고 • Jan 25+ 1 more updateMedMen Enterprises Inc. Announces Management ChangesMedMen Enterprises Inc. announced that Ellen Deutsch Harrison has stepped down as board member effective January 19, 2024 and the board has appointed Richard Ormond as chief restructuring officer. Furthermore, Michael Serruya, executive chairman of the board, who has served on the Board since August 2021, has stepped down from the Board effective January 24, 2024.
공고 • Nov 18MedMen Enterprises Inc. announced delayed 10-Q filingOn 11/17/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Sep 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 6.1% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$27m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$357m). Earnings have declined by 16% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (6.1% increase in shares outstanding). Market cap is less than US$100m (CA$50.8m market cap, or US$37.2m).
분석 기사 • Aug 16Why Investors Shouldn't Be Surprised By MedMen Enterprises Inc.'s (CSE:MMEN) Low P/SMedMen Enterprises Inc.'s ( CSE:MMEN ) price-to-sales (or "P/S") ratio of 0.3x may look like a pretty appealing...
공고 • Jul 06+ 2 more updatesMedMen Enterprises Inc. Appoints Ellen Deutsch to Board of DirectorsMedMen Enterprises Inc. announced the appointment of Ellen Deutsch to the Company’s Board of Directors, increasing the size of the Board of Directors to six. Deutsch brings deep operational, marketing, and financial experience and expertise in the cannabis and CPG industries, having most recently served as Senior Vice President of Market Development and Shared Services at Acreage Holdings. Before joining Acreage, Deutsch served as Executive Vice President/Chief Operating Officer at Stem Holdings, Inc, following two decades in the C-suite of Hain Celestial as its Senior Vice President/Chief Growth Officer among other leadership roles.
공고 • Jun 17MedMen Enterprises Inc. Announces CFO Changes, Effective June 29, 2023MedMen Enterprises Inc. announced the resignation of Ana Bowman as Chief Financial Officer, effective June 29, 2023. Bowman has served as CFO since 2022. MedMen has begun a formal search for a new CFO.
공고 • May 06MedMen Enterprises Inc. announced delayed 10-Q filingOn 05/05/2023, MedMen Enterprises Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
Reported Earnings • Feb 05Second quarter 2023 earnings released: US$0.011 loss per share (vs US$0.006 loss in 2Q 2022)Second quarter 2023 results: US$0.011 loss per share (further deteriorated from US$0.006 loss in 2Q 2022). Revenue: US$29.6m (down 17% from 2Q 2022). Net loss: US$14.0m (loss widened 103% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 57% per year, which means it is significantly lagging earnings.
Board Change • Dec 09High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • Sep 10MedMen Enterprises Inc. announced delayed annual 10-K filingOn 09/09/2022, MedMen Enterprises Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
Reported Earnings • Sep 09Full year 2022 earnings released: US$0.13 loss per share (vs US$0.22 loss in FY 2021)Full year 2022 results: US$0.13 loss per share. Revenue: US$140.8m (down 2.9% from FY 2021). Net loss: US$149.8m (loss widened 27% from FY 2021).
공고 • Aug 24An unknown buyer completed the acquisition of Substantially All of the Florida Assets of MedMen for $67 million.An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million on February 28, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The transaction is subject to pending receipt of all required contractual consents and governmental approvals including the requisite change of ownership approval from the Florida Office of Medical Marijuana Use and it is expected to close in late April or early May 2022. The agreement may be terminated, if the agreement is illegal or prohibited by the law, or if any of the conditions have not been satisfied by July 31, 2022. Hyperion Capital Inc. provided a fairness opinion to the special committee of the board of directors of MedMen. An unknown buyer completed the acquisition of Substantially All of the Florida Assets of MedMen on August 22, 2022. The deal is comprised of $63 million in cash and approximately $4 million in liabilities to be assumed by the buyer. The deal also includes the license of MedMen’s trademarks in the state.
Board Change • Jun 01High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • May 24+ 1 more updateMedMen Enterprises Inc. Announces Leaving of Tyson Rossi, Chief Strategy Officer, Effective June 3, 2022MedMen Enterprises Inc. announced Tyson Rossi, Chief Strategy Officer, is leaving MedMen, effective June 3, 2022. Moving forward, the role will be filled internally.
공고 • May 12Ascend Wellness Holdings, Inc. (CNSX:AAWH.U) entered into a definitive agreement to acquire New York Operations of MedMen Enterprises Inc. for $88 million.Ascend Wellness Holdings, Inc. (CNSX:AAWH.U) entered into a definitive agreement to acquire New York Operations of MedMen Enterprises Inc. for $88 million on May 11, 2022. The transaction resolves the litigation between MedMen and AWH concerning the transaction and delivers $15 million in additional value to MedMen shareholders. Under the terms of the settlement agreement, AWH will pay MedMen $88 million: $73 million as an assumption of debt and $15 million in cash. Other terms of the transaction will be as originally announced in February 2021. The transaction is expected to close within thirty days.
Reported Earnings • May 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: US$0.02 loss per share (up from US$0.039 loss in 3Q 2021). Revenue: US$35.2m (up 10% from 3Q 2021). Net loss: US$19.2m (loss narrowed 10% from 3Q 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) also missed analyst estimates by 487%.
공고 • Apr 28+ 1 more updateMedMen Enterprises Inc. Announces Appointment of Edward Record as Chief Executive OfficerMedMen Enterprises Inc. announced the appointment of Edward Record as Chief Executive Officer, effective immediately. Record succeeds interim CEO Michael Serruya, who will continue to serve as Chairman of the Board. Record joined MedMen’s Board of Directors in 2021. He previously served as the Chief Financial Officer for Hudson's Bay Company, whose U.S. holdings include Saks Fifth Avenue. Before joining HBC, Record was Chief Financial Officer for J.C. Penney. Prior to J.C. Penney, Record held leadership positions at Stage Stores, Kohl’s and Belk.
Board Change • Apr 27High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
공고 • Mar 01An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million.An unknown buyer agreed to acquire Substantially All of the Florida Assets of MedMen Enterprises Inc. (CNSX:MMEN) for $83 million on February 28, 2022. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The transaction is expected to close in late April or early May 2022, pending the receipt of all required contractual consents and governmental approvals including the requisite change of ownership approval from the Florida Office of Medical Marijuana Use. Hyperion Capital Inc. provided a fairness opinion to the special committee of the board of directors of MedMen.
공고 • Feb 19MedMen Announces CFO ChangesMedMen Enterprises Inc. announced the appointment of Ana Bowman as Chief Financial Officer, effective February 22, 2022. Bowman succeeds outgoing interim CFO Reece Fulgham, who will be returning to consulting firm SierraConstellation Partners.
공고 • Feb 13MedMen Announces Resignation of Tracy Mccourt as Chief Revenue Officer, Effective March 4, 2022MedMen Enterprises Inc. announced the Company has received notification from Tracy McCourt, the Company’s Chief Revenue Officer, of her decision to resign, effective March 4, 2022.
Reported Earnings • Feb 10Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: US$0.011 loss per share (up from US$0.083 loss in 2Q 2021). Revenue: US$39.1m (up 36% from 2Q 2021). Net loss: US$13.5m (loss narrowed 66% from 2Q 2021). Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 487%.
공고 • Feb 06MedMen Enterprises Inc., Annual General Meeting, Apr 20, 2022MedMen Enterprises Inc., Annual General Meeting, Apr 20, 2022.
공고 • Feb 02MedMen Enterprises Inc. Announces Cannasseur Personal Concierge ServiceMedMen Enterprises Inc. announced its Cannasseur Personal Concierge Service, a personal shopping program now available in California, Nevada, Arizona and Florida dispensaries. Led by MedMen’s top in-store cannabis experts, or ‘Cannaseurs’, the service offers customers free one-on-one consultations with seasoned budtenders, covering everything from individualized product and strain recommendations to cannabis education and responsible use. Every MedMen Cannasseur receives expert training through in-depth cannabis workshops and seminars with leading industry experts. A typical session will include questions about a consumer’s experience level, desired effect and preferred consumption format. Bringing best-in-class knowledge of cannabinoids, terpenes, cultivation methods, consumption formats and product offerings, their Cannaseurs take pride in advising and guiding patients towards the best product for their personal needs.
공고 • Jan 16Ascend Wellness Holdings, Inc. Announces the Filing of A Lawsuit and Motion for Preliminary Injunction for Specific Performance to Close Transaction with MedMenAscend Wellness Holdings, Inc. announced it has filed a complaint commencing a lawsuit in the Commercial Division of the Supreme Court of the State of New York in New York County against MedMen NY, Inc. and MM Enterprises USA, LLC in which AWH is seeking an order compelling specific performance of the transactions contemplated by the Investment Agreement among AWH and MedMen. In addition, AWH has made an application for a preliminary injunction and temporary restraining order to maintain the status quo between the parties and to prevent any actions by the MedMen parties that would result in additional encumbrances on the equity or assets of MedMen NY, Inc.
Board Change • Jan 01High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Board Change • Dec 03High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Cameron Smith is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 29Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 28Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 27Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyOn the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 26Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
Executive Departure • Nov 25Executive Chairman, CEO & Chief Restructuring Officer Thomas Lynch has left the companyDuring their tenure, earnings grew by 34% annually compared to the industry average of 31%. On the 22nd of November, Thomas Lynch was replaced as CEO by Michael Serruya after 1.6 years in the role. We don't have any record of a personal shareholding under Thomas' name. A total of 4 executives have left over the last 12 months. The current median tenure of the management team is less than a year, which is considered inexperienced in the Simply Wall St Risk Model. Under Thomas' leadership, the company delivered a total shareholder return of 1.6%.
